Literature DB >> 5638607

Attempts to find human adenovirus type-12 tumor antigens in human tumors.

K J McCormick, G L Van Hoosier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5638607

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

Review 1.  Oncogenic properties of human viruses.

Authors:  R Glaser; B Decker; F Rapp
Journal:  In Vitro       Date:  1975 May-Jun

2.  Complement-fixing antigens in lymphoid cell lines of American origin.

Authors:  K J McCormick; D M Mumford; W A Stenback; J J Trentin
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

3.  Isolation and characterization of an Avian adenovirus-associated virus.

Authors:  V J Yates; A M el-Mishad; K J McCormick; J J Trentin
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

4.  Complement-fixation test for detection of herpes-like viruses in cell cultures of Burkitt's lymphoma.

Authors:  K J McCormick; W A Stenback; J J Trentin; G Klein; J S Nadkarni; J J Nadkarni; P Clifford
Journal:  J Virol       Date:  1969-05       Impact factor: 5.103

5.  Detection and serological identification of adeno-associated virus in avian adenovirus stocks.

Authors:  A M El Mishad; K J McCormick; V J Yates; J J Trentin
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

6.  Complement-fixing antigens in Burkitt lymphoma cell lines.

Authors:  K J McCormick; W A Stenback; D M Mumford; J J Trentin
Journal:  Infect Immun       Date:  1971-07       Impact factor: 3.441

7.  Are human DNA tumour viruses involved in the pathogenesis of human neurogenic tumors?

Authors:  H Ibelgaufts
Journal:  Neurosurg Rev       Date:  1982       Impact factor: 3.042

8.  Adenovirus-related RNA sequences in human neurogenic tumours.

Authors:  H Ibelgaufts; K W Jones; N Maitland; J F Shaw
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.